Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 3
2020 1
2021 5
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Butler CC, Hobbs FDR, Gbinigie OA, Rahman NM, Hayward G, Richards DB, Dorward J, Lowe DM, Standing JF, Breuer J, Khoo S, Petrou S, Hood K, Nguyen-Van-Tam JS, Patel MG, Saville BR, Marion J, Ogburn E, Allen J, Rutter H, Francis N, Thomas NPB, Evans P, Dobson M, Madden TA, Holmes J, Harris V, Png ME, Lown M, van Hecke O, Detry MA, Saunders CT, Fitzgerald M, Berry NS, Mwandigha L, Galal U, Mort S, Jani BD, Hart ND, Ahmed H, Butler D, McKenna M, Chalk J, Lavallee L, Hadley E, Cureton L, Benysek M, Andersson M, Coates M, Barrett S, Bateman C, Davies JC, Raymundo-Wood I, Ustianowski A, Carson-Stevens A, Yu LM, Little P; PANORAMIC Trial Collaborative Group. Butler CC, et al. Among authors: mwandigha l. Lancet. 2023 Jan 28;401(10373):281-293. doi: 10.1016/S0140-6736(22)02597-1. Epub 2022 Dec 22. Lancet. 2023. PMID: 36566761 Free PMC article. Clinical Trial.
Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study.
Chandna A, Mahajan R, Gautam P, Mwandigha L; PRIORITISE Study Investigators; Kumar P, Varghese GM, Koshiaris C, Lubell Y, Burza S. Chandna A, et al. Among authors: mwandigha l. Open Forum Infect Dis. 2022 Oct 6;9(10):ofac526. doi: 10.1093/ofid/ofac526. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36320192 Free PMC article.
Defining the role of host biomarkers in the diagnosis and prognosis of the severity of childhood pneumonia: a prospective cohort study.
Chandna A, Lubell Y, Mwandigha L, Tanunchai P, Vinitsorn A, Richard-Greenblatt M, Koshiaris C, Limmathurotsakul D, Nosten F, Abdad MY, Perera-Salazar R, Turner C, Turner P. Chandna A, et al. Among authors: mwandigha l. Sci Rep. 2023 Jul 25;13(1):12024. doi: 10.1038/s41598-023-38731-4. Sci Rep. 2023. PMID: 37491541 Free PMC article.
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings.
Chandna A, Mahajan R, Gautam P, Mwandigha L, Gunasekaran K, Bhusan D, Cheung ATL, Day N, Dittrich S, Dondorp A, Geevar T, Ghattamaneni SR, Hussain S, Jimenez C, Karthikeyan R, Kumar S, Kumar S, Kumar V, Kundu D, Lakshmanan A, Manesh A, Menggred C, Moorthy M, Osborn J, Richard-Greenblatt M, Sharma S, Singh VK, Singh VK, Suri J, Suzuki S, Tubprasert J, Turner P, Villanueva AMG, Waithira N, Kumar P, Varghese GM, Koshiaris C, Lubell Y, Burza S. Chandna A, et al. Among authors: mwandigha l. Clin Infect Dis. 2022 Aug 24;75(1):e368-e379. doi: 10.1093/cid/ciac224. Clin Infect Dis. 2022. PMID: 35323932 Free PMC article. Clinical Trial.
Feasibility and Acceptability of Community Coronavirus Disease 2019 Testing Strategies (FACTS) in a University Setting.
Hirst JA, Logan M, Fanshawe TR, Mwandigha L, Wanat M, Vicary C, Perera R, Tonkin-Crine S, Lee JJ, Tracey I, Duff G, Tufano P, Besharov M, Tarassenko L, Nicholson BD, Hobbs FDR. Hirst JA, et al. Among authors: mwandigha l. Open Forum Infect Dis. 2021 Oct 4;8(12):ofab495. doi: 10.1093/ofid/ofab495. eCollection 2021 Dec. Open Forum Infect Dis. 2021. PMID: 34904117 Free PMC article.
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test.
Chandna A, Mahajan R, Gautam P, Mwandigha L, Dittrich S, Kumar V, Osborn J, Kumar P, Koshiaris C, Varghese GM, Lubell Y, Burza S. Chandna A, et al. Among authors: mwandigha l. PLOS Glob Public Health. 2023 Aug 21;3(8):e0001538. doi: 10.1371/journal.pgph.0001538. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37603548 Free PMC article.
Feeding rates of malaria vectors from a prototype attractive sugar bait station in Western Province, Zambia: results of an entomological validation study.
Chanda J, Wagman J, Chanda B, Kaniki T, Ng'andu M, Muyabe R, Mwenya M, Sakala J, Miller J, Mwaanga G, Simubali L, Mburu MM, Simulundu E, Mungo A, Fraser K, Mwandigha L, Ashton R, Yukich J, Harris AF, Burkot TR, Orange E, Littrell M, Entwistle J. Chanda J, et al. Among authors: mwandigha l. Malar J. 2023 Mar 1;22(1):70. doi: 10.1186/s12936-023-04491-9. Malar J. 2023. PMID: 36855105 Free PMC article.
20 results